Scientist I, Mammalian Cell Line Development
Novartis-Cambridge, MA, 02138
Over the past several years, Novartis has had the greatest number of new molecular entities approved by the FDA for clinical use in the US. Novartis is expanding its biologics capabilities to leverage its deep disease area expertise and innovative internal research, as well as to develop discoveries made at leading academic institutions and biotechnology companies. The Novartis Biologics Unit (NBx) is a dedicated biologics discovery and development organization created to accelerate the advancement of Novartis' rich and rapidly expanding biologics pipeline. The Process Sciences and Producti...